|
Kwality Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
1001.67 Cr.
|
P/BV
|
4.16
|
Book Value (Rs.)
|
232.30
|
|
52 Week High/Low (Rs.)
|
1235/596
|
FV/ML
|
10/1
|
P/E(X)
|
25.14
|
|
Bookclosure
|
24/09/2024
|
EPS (Rs.)
|
38.40
|
Div Yield (%)
|
0.03
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 38.36 | 22.76 | 18.16 | 115.64 | 14.60 |
| Diluted EPS (Rs.) | 38.36 | 22.76 | 18.16 | 115.64 | 14.60 |
| Cash EPS (Rs.) | 55.99 | 41.61 | 33.00 | 125.89 | 20.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 253.70 | 213.74 | 191.08 | 172.50 | 56.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 254.47 | 214.51 | 191.85 | 173.27 | 57.68 |
| Revenue From Operations / Share (Rs.) | 356.77 | 296.03 | 241.93 | 439.64 | 252.51 |
| PBDIT / Share (Rs.) | 79.32 | 65.67 | 60.79 | 168.82 | 29.33 |
| PBIT / Share (Rs.) | 61.70 | 46.82 | 46.38 | 158.52 | 23.07 |
| PBT / Share (Rs.) | 52.18 | 29.97 | 24.65 | 155.71 | 20.50 |
| Net Profit / Share (Rs.) | 38.36 | 22.76 | 18.58 | 115.59 | 14.35 |
| NP After MI And SOA / Share (Rs.) | 38.40 | 22.93 | 18.67 | 115.64 | 14.60 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 22.23 | 22.18 | 25.12 | 38.39 | 11.61 |
| PBIT Margin (%) | 17.29 | 15.81 | 19.16 | 36.05 | 9.13 |
| PBT Margin (%) | 14.62 | 10.12 | 10.18 | 35.41 | 8.11 |
| Net Profit Margin (%) | 10.75 | 7.68 | 7.68 | 26.29 | 5.68 |
| NP After MI And SOA Margin (%) | 10.76 | 7.74 | 7.71 | 26.30 | 5.78 |
| Return on Networth / Equity (%) | 15.13 | 10.65 | 9.69 | 66.53 | 25.09 |
| Return on Capital Employeed (%) | 23.04 | 20.04 | 21.13 | 78.21 | 27.21 |
| Return On Assets (%) | 8.90 | 6.03 | 5.47 | 35.23 | 9.10 |
| Long Term Debt / Equity (X) | 0.05 | 0.08 | 0.13 | 0.11 | 0.30 |
| Total Debt / Equity (X) | 0.42 | 0.43 | 0.45 | 0.24 | 0.57 |
| Asset Turnover Ratio (%) | 0.87 | 0.82 | 0.72 | 1.79 | 1.73 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.67 | 1.60 | 1.65 | 1.75 | 1.35 |
| Quick Ratio (X) | 1.18 | 1.08 | 0.95 | 1.34 | 1.13 |
| Inventory Turnover Ratio (X) | 4.57 | 1.87 | 1.62 | 5.64 | 8.31 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 8.33 | 6.56 | 10.48 | 60.05 | 11.39 |
| Interest Coverage Ratio (Post Tax) (%) | 5.03 | 3.96 | 6.95 | 42.11 | 6.57 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 997.78 | 515.35 | 400.57 | 630.81 | 85.72 |
| EV / Net Operating Revenue (X) | 2.70 | 1.68 | 1.60 | 1.38 | 0.32 |
| EV / EBITDA (X) | 12.12 | 7.56 | 6.35 | 3.60 | 2.82 |
| MarketCap / Net Operating Revenue (X) | 2.44 | 1.38 | 1.27 | 1.32 | 0.22 |
| Price / BV (X) | 3.43 | 1.90 | 1.60 | 3.34 | 0.96 |
| Price / Net Operating Revenue (X) | 2.44 | 1.38 | 1.27 | 1.32 | 0.22 |
| EarningsYield | 0.04 | 0.05 | 0.06 | 0.19 | 0.26 |
